Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 1619-16-5
2. (e)-3-[(1r,4s,7r,7ar)-1-hydroxy-3,7-dimethyl-2,4,5,6,7,7a-hexahydro-1h-inden-4-yl]-2-methylprop-2-enoic Acid
3. 043w90dl5f
4. Hydroxyvalerenic Acid (constituent Of Valerian) [dsc]
5. Unii-043w90dl5f
6. Hydroxyvalerensaure
7. Hydroxyvalerens?ure
8. Dsstox_cid_13564
9. Dsstox_rid_79085
10. Dsstox_gsid_33564
11. Schembl4543164
12. Chembl1565922
13. Dtxsid8033564
14. Hy-n7262
15. Tox21_200020
16. Mfcd00189426
17. Zinc17263716
18. Ncgc00091907-01
19. Ncgc00091907-02
20. Ncgc00091907-03
21. Ncgc00257574-01
22. (2e)-3-[(1r,4s,7r,7ar)-1-hydroxy-3,7-dimethyl-2,4,5,6,7,7a-hexahydro-1h-inden-4-yl]-2-methylacrylic Acid
23. Cas-1619-16-5
24. Cs-0110986
25. 2-propenoic Acid, 3-[(1r,4s,7r,7ar)-2,4,5,6,7,7a-hexahydro-1-hydroxy-3,7-dimethyl-1h-inden-4-yl]-2-methyl-, (2e)-
26. Ncgc00091907-03_c15h22o3_(2e)-3-[(1r,4s,7r,7ar)-1-hydroxy-3,7-dimethyl-2,4,5,6,7,7a-hexahydro-1h-inden-4-yl]-2-methylacrylic Acid
| Molecular Weight | 250.33 g/mol |
|---|---|
| Molecular Formula | C15H22O3 |
| XLogP3 | 2.1 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 2 |
| Exact Mass | 250.15689456 g/mol |
| Monoisotopic Mass | 250.15689456 g/mol |
| Topological Polar Surface Area | 57.5 Ų |
| Heavy Atom Count | 18 |
| Formal Charge | 0 |
| Complexity | 420 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 4 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Hydroxyvalerenic Acid manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Hydroxyvalerenic Acid, including repackagers and relabelers. The FDA regulates Hydroxyvalerenic Acid manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Hydroxyvalerenic Acid API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Hydroxyvalerenic Acid supplier is an individual or a company that provides Hydroxyvalerenic Acid active pharmaceutical ingredient (API) or Hydroxyvalerenic Acid finished formulations upon request. The Hydroxyvalerenic Acid suppliers may include Hydroxyvalerenic Acid API manufacturers, exporters, distributors and traders.
Hydroxyvalerenic Acid Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Hydroxyvalerenic Acid GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Hydroxyvalerenic Acid GMP manufacturer or Hydroxyvalerenic Acid GMP API supplier for your needs.
A Hydroxyvalerenic Acid CoA (Certificate of Analysis) is a formal document that attests to Hydroxyvalerenic Acid's compliance with Hydroxyvalerenic Acid specifications and serves as a tool for batch-level quality control.
Hydroxyvalerenic Acid CoA mostly includes findings from lab analyses of a specific batch. For each Hydroxyvalerenic Acid CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Hydroxyvalerenic Acid may be tested according to a variety of international standards, such as European Pharmacopoeia (Hydroxyvalerenic Acid EP), Hydroxyvalerenic Acid JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Hydroxyvalerenic Acid USP).
LOOKING FOR A SUPPLIER?
